Hospital chains scaling bed capacity while diagnostics benefit from preventive health awareness and insurance penetration.
| Company | M.Cap | Price | P/E | P/B | ROE | ROCE | D/E | Div Yield | 1Y Return |
|---|---|---|---|---|---|---|---|---|---|
| Dr. Agarwals Health Care Ltd | ₹14,010 Cr | ₹481.1 | 111.6 | 7.2 | 0.0% | 35.3% | 0.5 | 0.0% | -10.59% |
| Fabtech Technologies Ltd | ₹669 Cr | ₹153.55 | 15.0 | 1.4 | 12.9% | 7.4% | 0.2 | 0.4% | -37.68% |
| Fischer Medical Ventures Ltd | ₹2,284 Cr | ₹34.76 | 59.2 | 6.3 | 0.0% | 6.4% | 0.1 | 0.0% | -51.94% |
| Inventurus Knowledge Solutions Ltd | ₹26,681 Cr | ₹1,619.2 | 37.7 | 11.9 | 0.0% | 31.2% | 0.3 | 0.0% | -3.62% |
| Indegene Ltd | ₹12,256 Cr | ₹509.25 | 28.0 | 4.3 | 13.9% | 18.3% | 0.1 | 0.4% | +0.28% |
| Krsnaa Diagnostics Ltd | ₹1,837 Cr | ₹561.9 | 23.2 | 2.0 | 0.0% | 24.5% | 0.3 | 0.0% | -30.19% |
| Dr. Lal PathLabs Ltd | ₹27,374 Cr | ₹1,680.8 | 51.9 | 11.5 | 21.5% | 31.0% | 0.1 | 0.9% | +6.95% |
| Laxmi Dental Ltd | ₹1,123 Cr | ₹207.74 | 48.5 | 4.8 | 0.0% | 0.0% | 0.0 | 0.0% | -38.49% |
| Lenskart Solutions Ltd | ₹81,140 Cr | ₹498.5 | 136.8 | 12.4 | -0.2% | 0.0% | 44.2 | 0.0% | +13.07% |
| Metropolis Healthcare Ltd | ₹10,520 Cr | ₹528.8 | 55.2 | 7.3 | 13.4% | 17.1% | 0.2 | 0.0% | +2.92% |
| Nureca Ltd | ₹259 Cr | ₹271.8 | 24.6 | 1.6 | 0.0% | -10.0% | 0.0 | 0.0% | -1.30% |
| Poly Medicure Ltd | ₹14,769 Cr | ₹1,550.6 | 42.6 | 5.1 | 0.0% | 30.8% | 0.1 | 0.0% | -28.35% |
| Sagility Ltd | ₹19,250 Cr | ₹41.43 | 20.8 | 2.2 | 0.0% | 12.7% | 0.1 | 0.0% | -19.88% |
| Sai Life Sciences Ltd | ₹23,346 Cr | ₹1,138.1 | 69.6 | 10.2 | 15.1% | 27.1% | 0.1 | 0.0% | +25.01% |
| Suraksha Diagnostic Ltd | ₹1,594 Cr | ₹320.1 | 49.0 | 6.9 | 0.0% | 19.8% | 0.5 | 0.0% | -4.31% |
| Syngene International Ltd | ₹18,716 Cr | ₹470.2 | 53.4 | 4.0 | 6.6% | 13.7% | 0.1 | 0.3% | -29.74% |
| Tarsons Products Ltd | ₹1,104 Cr | ₹211.03 | 54.1 | 1.8 | 0.0% | 6.7% | 0.6 | 0.0% | -20.86% |
| Thyrocare Technologies Ltd | ₹7,197 Cr | ₹469.05 | 44.1 | 13.5 | 28.8% | 36.3% | 0.1 | 2.0% | -3.01% |
| Universus Photo Imagings Ltd | ₹511 Cr | ₹415.15 | 0.0 | 0.6 | 0.0% | -0.3% | 0.0 | 0.0% | +65.95% |
| Vijaya Diagnostic Centre Ltd | ₹13,405 Cr | ₹1,259.3 | 77.8 | 15.5 | 0.0% | 18.3% | 0.4 | 0.0% | +27.25% |
| Vimta Labs Ltd-$ | ₹2,011 Cr | ₹450.3 | 26.2 | 4.8 | 18.6% | 32.7% | 0.0 | 0.0% | -30.75% |
| Adeshwar Meditex Ltd | ₹24 Cr | ₹16.43 | 12.5 | 0.6 | 14.3% | 0.0% | 0.0 | 0.0% | +9.53% |
| Deep Health AI India Ltd | ₹34 Cr | ₹2.21 | 5.2 | 0.4 | 8.3% | 0.0% | 0.0 | 858.0% | -51.32% |
| Prevest Denpro Ltd | ₹485 Cr | ₹404.1 | 24.5 | 4.2 | 21.2% | 0.0% | 0.0 | 25.0% | -14.38% |
| Star Imaging And Path Lab Ltd | ₹126 Cr | ₹72.48 | 6.4 | 1.2 | 33.3% | 0.0% | 0.0 | 0.0% | 0.00% |
| Centenial Surgical Suture Ltd | ₹36 Cr | ₹94 | 0.0 | 1.3 | -3.3% | 0.0% | 0.0 | 0.0% | +4.44% |
| Earkart Ltd | ₹205 Cr | ₹148.75 | 29.8 | 3.1 | 36.8% | 0.0% | 0.0 | 0.0% | 0.00% |
| Modern Diagnostic & Research Centre Ltd | ₹122 Cr | ₹81 | 13.6 | 3.8 | 42.9% | 0.0% | 0.0 | 0.0% | 0.00% |
| KMS Medisurgi Ltd | ₹44 Cr | ₹132.8 | 74.2 | 5.3 | 0.0% | 0.0% | 0.0 | 4.0% | +6.24% |
| GKB Ophthalmics Ltd | ₹32 Cr | ₹63.55 | 0.0 | 0.6 | -25.0% | 0.0% | 0.0 | 0.0% | -4.64% |
| Hemant Surgical Industries Ltd | ₹532 Cr | ₹407.7 | 56.8 | 3.5 | 80.0% | 0.0% | 0.0 | 0.0% | +318.15% |
| Vanta Bioscience Ltd | ₹13 Cr | ₹18 | 0.0 | 0.7 | 0.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Aspira Pathlab & Diagnostics Ltd | ₹94 Cr | ₹90.99 | 65.9 | 6.5 | 0.0% | 0.0% | 0.0 | 0.0% | +47.35% |
| Qualitek Labs Ltd | ₹354 Cr | ₹355 | 37.1 | 2.5 | 24.0% | 0.0% | 0.0 | 0.0% | +13.44% |
| Dr Lalchandani Labs Ltd | ₹6 Cr | ₹9.67 | 12.6 | 0.4 | 0.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Amkay Products Ltd | ₹52 Cr | ₹59.99 | 14.8 | 2.0 | 33.3% | 0.0% | 0.0 | 0.0% | -4.38% |
| Maestros Electronics & Telecommunications Systems Ltd | ₹74 Cr | ₹136.9 | 12.6 | 2.0 | 13.3% | 0.0% | 0.0 | 0.0% | -11.19% |
| Clinitech Laboratory Ltd | ₹9 Cr | ₹39.5 | 13.0 | 0.7 | 0.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Dolphin Medical Services Ltd | ₹10 Cr | ₹6.83 | 0.0 | 1.2 | 0.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Choksi Laboratories Ltd | ₹73 Cr | ₹101 | 39.3 | 3.0 | 9.1% | 0.0% | 0.0 | 0.0% | -15.34% |
| Samsrita Labs Ltd | ₹36 Cr | ₹15.3 | 0.0 | 2.1 | 0.0% | 0.0% | 0.0 | 0.0% | -26.58% |
| Gian Life Care Ltd | ₹6 Cr | ₹6.05 | 0.0 | 0.3 | 0.0% | 0.0% | 0.0 | 0.0% | -62.88% |
| Shree Pacetronix Ltd | ₹51 Cr | ₹127 | 19.9 | 3.1 | 7.7% | 0.0% | 0.0 | 0.0% | +81.17% |
| Choksi Asia Ltd | ₹79 Cr | ₹134 | 15.2 | 2.0 | 11.1% | 0.0% | 0.0 | 0.0% | +72.02% |
India's healthcare sector is valued at $372 billion and growing at 15-20% annually. Hospital bed density at 1.3 per 1,000 people is among the lowest globally, creating a massive expansion opportunity. Listed hospital chains (Apollo, Max, Fortis) are adding beds aggressively while improving ARPOB (Average Revenue Per Occupied Bed).
Medical tourism brings $9 billion annually with India offering procedures at 1/10th the cost of the US. Health insurance penetration is rising rapidly from a low base, making healthcare more accessible. Key metrics: ARPOB, occupancy rates, bed additions, and payor mix (insurance vs out-of-pocket).
The sector trades at premium valuations (40-60x PE) due to scarcity and structural tailwinds.
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.